Prostate Cancer

Latest News

Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer

July 24th 2024

"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.

UK study of AI-based software for prostate cancer detection expands
UK study of AI-based software for prostate cancer detection expands

July 22nd 2024

3d rendered illustration of prostate cancer | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
Conventional and next-generation imaging evaluation of biochemically recurrent prostate cancer

July 22nd 2024

Trial expands to evaluate ORIC-944 with AR inhibitors in prostate cancer
Trial expands to evaluate ORIC-944 with AR inhibitors in prostate cancer

July 17th 2024

Adding darolutamide to ADT extends rPFS in mHSPC
Adding darolutamide to ADT extends rPFS in mHSPC

July 17th 2024

Video Series
Video Interviews
Podcasts
medical depiction of prostate cancer
Urology Times Speaking of Urology® logo

More News

© 2024 MJH Life Sciences

All rights reserved.